Original language | English (US) |
---|---|
Pages (from-to) | 1155 |
Number of pages | 1 |
Journal | JAMA neurology |
Volume | 75 |
Issue number | 9 |
DOIs | |
State | Published - Sep 2018 |
ASJC Scopus subject areas
- Clinical Neurology
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Orthostatic hypotension as a prodromal marker of α-synucleinopathies-Reply. / Savica, Rodolfo; Boeve, Bradley F.; Mielke, Michelle M.
In: JAMA neurology, Vol. 75, No. 9, 09.2018, p. 1155.Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - Orthostatic hypotension as a prodromal marker of α-synucleinopathies-Reply
AU - Savica, Rodolfo
AU - Boeve, Bradley F.
AU - Mielke, Michelle M.
N1 - Funding Information: Author Affiliations: Department of Neurology, Dysautonomia Center, New York University School of Medicine, New York. Corresponding Author: Horacio Kaufmann, MD, Department of Neurology, Dysautonomia Center, New York University School of Medicine, 530 First Ave, Ste 9Q, New York, NY 10016 (horacio.kaufmann@nyumc.org). Published Online: August 13, 2018. doi:10.1001/jamaneurol.2018.2248 Conflict of Interest Disclosures: The authors receive funding from National Institutes of Health grant U54NS065736. 1. Savica R, Boeve BF, Mielke MM. When do α-synucleinopathies start? an epidemiological timeline: a review. JAMA Neurol. 2018;75(4):503-509. doi:10.1001/jamaneurol.2017.4243 2. Kaufmann H, Norcliffe-Kaufmann L, Palma JA, et al; Autonomic Disorders Consortium. Natural history of pure autonomic failure: a United States prospective cohort. Ann Neurol. 2017;81(2):287-297. doi:10.1002/ana.24877 3. Postuma RB, Gagnon JF, Pelletier A, Montplaisir J. Prodromal autonomic symptoms and signs in Parkinson’s disease and dementia with Lewy bodies. Mov Disord. 2013;28(5):597-604. doi:10.1002/mds.25445 4. Schrag A, Horsfall L, Walters K, Noyce A, Petersen I. Prediagnostic presentations of Parkinson’s disease in primary care: a case-control study. Lancet Neurol. 2015;14(1):57-64. doi:10.1016/S1474-4422(14)70287-X 5. Berg D, Postuma RB, Adler CH, et al. MDS research criteria for prodromal Parkinson’s disease. Mov Disord. 2015;30(12):1600-1611. doi:10.1002/mds.26431 Funding Information: Conflict of Interest Disclosures: Our research is supported by grants from Fundação de Amparo à Pesquisa do Estado de São Paulo, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, and Instituto Nacional de Neurociência Translacional. 1. Devinsky O, Ryvlin P, Friedman D. Preventing sudden unexpected death in epilepsy. JAMA Neurol. 2018;75(5):531-532. doi:10.1001/jamaneurol.2018.0400 2. Watkins L, Shankar R, Sander JW. Identifying and mitigating Sudden Unexpected Death in Epilepsy (SUDEP) risk factors. Expert Rev Neurother. 2018;18(4):265-274. doi:10.1080/14737175.2018.1439738 3. Scorza FA, Cysneiros RM, Arida RM, Terra-Bustamante VC, de Albuquerque M, Cavalheiro EA. The other side of the coin: beneficiary effect of omega-3 fatty acids in sudden unexpected death in epilepsy. Epilepsy Behav. 2008;13(2):279-283. doi:10.1016/j.yebeh.2008.04.011
PY - 2018/9
Y1 - 2018/9
UR - http://www.scopus.com/inward/record.url?scp=85052695550&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85052695550&partnerID=8YFLogxK
U2 - 10.1001/jamaneurol.2018.2251
DO - 10.1001/jamaneurol.2018.2251
M3 - Letter
C2 - 30105350
AN - SCOPUS:85052695550
VL - 75
SP - 1155
JO - JAMA Neurology
JF - JAMA Neurology
SN - 2168-6149
IS - 9
ER -